Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer

NCT07665684 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Ductal Adenocarcinoma
Pancreas Cancer, Metastatic
Pancreatic Adenocarcinoma Metastatic
Adenosquamous Carcinoma of the Pancreas
Mucinous Adenocarcinoma

Interventions

DRUG: Samuraciclib + Gemcitabine & Nab-Paclitaxel

Sponsor

University Health Network, Toronto